IRadimed Corporation IRMD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.15% | 0.28% | 12.65% | 17.03% | 15.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.15% | 0.28% | 12.65% | 17.03% | 15.69% |
| Cost of Revenue | 22.07% | 19.13% | 10.65% | 22.30% | 13.88% |
| Gross Profit | 11.90% | -4.98% | 13.28% | 15.38% | 16.22% |
| SG&A Expenses | 5.06% | -2.15% | -1.89% | 8.73% | 15.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.80% | 3.33% | 4.71% | 14.79% | 14.61% |
| Operating Income | 19.11% | -5.85% | 33.23% | 22.30% | 18.03% |
| Income Before Tax | 18.79% | -5.99% | 30.68% | 22.80% | 13.69% |
| Income Tax Expenses | 25.62% | 7.53% | 55.09% | 12.65% | 25.73% |
| Earnings from Continuing Operations | 16.68% | -9.63% | 24.13% | 25.17% | 10.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.68% | -9.63% | 24.13% | 25.17% | 10.43% |
| EBIT | 19.11% | -5.85% | 33.23% | 22.30% | 18.03% |
| EBITDA | 18.50% | -2.79% | 36.72% | 24.66% | 20.53% |
| EPS Basic | 16.08% | -10.11% | 23.47% | 24.62% | 9.99% |
| Normalized Basic EPS | 18.19% | -6.50% | 30.01% | 19.02% | 13.23% |
| EPS Diluted | 18.33% | -9.29% | 22.08% | 24.76% | 7.90% |
| Normalized Diluted EPS | 18.64% | -6.28% | 30.24% | 18.92% | 12.97% |
| Average Basic Shares Outstanding | 0.52% | 0.53% | 0.54% | 0.43% | 0.40% |
| Average Diluted Shares Outstanding | 0.12% | 0.29% | 0.34% | 0.50% | 0.64% |
| Dividend Per Share | 17.65% | 17.65% | 17.65% | 17.65% | 13.33% |
| Payout Ratio | 0.01% | 0.31% | -0.05% | 2.60% | 0.03% |